Use of a new end‐stage kidney disease risk calculator in the Kidney Disease Improving Global Outcomes guideline to evaluate the impact of different living kidney donor candidate assessments. Issue 7 (24th July 2018)
- Record Type:
- Journal Article
- Title:
- Use of a new end‐stage kidney disease risk calculator in the Kidney Disease Improving Global Outcomes guideline to evaluate the impact of different living kidney donor candidate assessments. Issue 7 (24th July 2018)
- Main Title:
- Use of a new end‐stage kidney disease risk calculator in the Kidney Disease Improving Global Outcomes guideline to evaluate the impact of different living kidney donor candidate assessments
- Authors:
- Lee, Darren
Manzoor, Momena
Harley, Geoff
Whitlam, John
Cook, Natasha
Choy, Suet‐wan
Sandiford, Megan
Gibson, Charlotte
McMahon, Lawrence P
Roberts, Matthew A - Abstract:
- Abstract: Aim: The Kidney Disease Improving Global Outcomes (KDIGO) guideline recommends the incorporation of a new risk calculator that quantifies the end‐stage kidney disease (ESKD) risk based on a composite profile of risk factors in living kidney donor candidates (LKDC). We compared the ESKD risk estimates in previously declined versus accepted LKDC to evaluate the predictive capacity and potential impact of this tool. Methods: Baseline 15 year and lifetime ESKD risk estimates without donation were calculated using the risk calculator for LKDC assessed from two centres between 2007 and 2015. LKDC suitability based on the proposed KDIGO and the existing Caring for Australasians with Renal Impairment national guidelines was compared. Results: Median 15 year ESKD risk was 0.14% (IQR 0.09–0.31%) in declined LKDC ( n =59) versus 0.10% (0.07–0.14%) in accepted LKDC ( n =89) ( P <0.001). Lifetime risk was similar: 0.39% (0.23–0.80%) versus 0.35% (0.22–0.56%), respectively; however, declined LKDC had a higher 98% risk percentile value (8.19% vs 1.02%) and were more likely to exceed a 1% ESKD risk threshold (15% vs 1%; P <0.01). The calculator captured reasons for declining donation in only 39% of LKDC; 46.9% of LKDC with Caring for Australasians with Renal Impairment contraindications were reclassified as having an acceptable (≤1%) lifetime risk and no KDIGO contraindications, primarily related to a lower pre‐donation glomerular filtration rate or controlled hypertension withAbstract: Aim: The Kidney Disease Improving Global Outcomes (KDIGO) guideline recommends the incorporation of a new risk calculator that quantifies the end‐stage kidney disease (ESKD) risk based on a composite profile of risk factors in living kidney donor candidates (LKDC). We compared the ESKD risk estimates in previously declined versus accepted LKDC to evaluate the predictive capacity and potential impact of this tool. Methods: Baseline 15 year and lifetime ESKD risk estimates without donation were calculated using the risk calculator for LKDC assessed from two centres between 2007 and 2015. LKDC suitability based on the proposed KDIGO and the existing Caring for Australasians with Renal Impairment national guidelines was compared. Results: Median 15 year ESKD risk was 0.14% (IQR 0.09–0.31%) in declined LKDC ( n =59) versus 0.10% (0.07–0.14%) in accepted LKDC ( n =89) ( P <0.001). Lifetime risk was similar: 0.39% (0.23–0.80%) versus 0.35% (0.22–0.56%), respectively; however, declined LKDC had a higher 98% risk percentile value (8.19% vs 1.02%) and were more likely to exceed a 1% ESKD risk threshold (15% vs 1%; P <0.01). The calculator captured reasons for declining donation in only 39% of LKDC; 46.9% of LKDC with Caring for Australasians with Renal Impairment contraindications were reclassified as having an acceptable (≤1%) lifetime risk and no KDIGO contraindications, primarily related to a lower pre‐donation glomerular filtration rate or controlled hypertension with obesity. Conclusion: Declined LKDC had a higher 15 year but similar lifetime ESKD risk. However, the calculator successfully differentiated declined LKDC with a lifetime risk >1%. This risk calculator appears to complement but not replace clinical evaluation. Summary at a Glance: A paper looking at incorporating the end‐stage kidney disease risk calculator developed for non‐donors to assess the impact of living kidney donor candidate assessment and selection (declined vs accepted donors) with either the Caring for Australasians with Renal Impairment or Kidney Disease Improving Global Outcomes guidelines. … (more)
- Is Part Of:
- Nephrology. Volume 23:Issue 7(2018)
- Journal:
- Nephrology
- Issue:
- Volume 23:Issue 7(2018)
- Issue Display:
- Volume 23, Issue 7 (2018)
- Year:
- 2018
- Volume:
- 23
- Issue:
- 7
- Issue Sort Value:
- 2018-0023-0007-0000
- Page Start:
- 616
- Page End:
- 624
- Publication Date:
- 2018-07-24
- Subjects:
- KDIGO guideline -- kidney transplantation -- living kidney donation -- risk calculator
Nephrology -- Periodicals
Kidneys -- Diseases -- Periodicals
Nephrologists -- Periodicals
616.61
616.61 - Journal URLs:
- http://onlinelibrary.wiley.com/ ↗
- DOI:
- 10.1111/nep.13074 ↗
- Languages:
- English
- ISSNs:
- 1320-5358
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6075.684400
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 7067.xml